Satellos Bioscience Inc. (MSCL.TO)

CAD 0.64

(1.59%)

Inventory Summary of Satellos Bioscience Inc.

  • Satellos Bioscience Inc.'s latest annual inventory in 2023 was -583 Thousand CAD , down -124.23% from previous year.
  • Satellos Bioscience Inc.'s latest quarterly inventory in 2024 Q1 was -895 Thousand CAD , down -53.52% from previous quarter.
  • Satellos Bioscience Inc. reported annual inventory of -260 Thousand CAD in 2022, up 50.76% from previous year.
  • Satellos Bioscience Inc. reported annual inventory of -527.98 Thousand CAD in 2021, down -29.07% from previous year.
  • Satellos Bioscience Inc. reported quarterly inventory of -895 Thousand CAD for 2024 Q1, down -53.52% from previous quarter.
  • Satellos Bioscience Inc. reported quarterly inventory of -583 Thousand CAD for 2023 FY, down -124.23% from previous quarter.

Annual Inventory Chart of Satellos Bioscience Inc. (2023 - 2019)

Created with Highcharts 11.1.0YearsInventory20192019.520202020.520212021.520222022.52023-700000 CAD-600000 CAD-500000 CAD-400000 CAD-300000 CAD-200000 CAD-100000 CAD0 CAD

Historical Annual Inventory of Satellos Bioscience Inc. (2023 - 2019)

Year Inventory Inventory Growth
2023 -583 Thousand CAD -124.23%
2022 -260 Thousand CAD 50.76%
2021 -527.98 Thousand CAD -29.07%
2020 -409.08 Thousand CAD 0.0%
2019 - CAD 0.0%

Peer Inventory Comparison of Satellos Bioscience Inc.

Name Inventory Inventory Difference
Appili Therapeutics Inc. - CAD Infinity%
Eupraxia Pharmaceuticals Inc. 1.00 CAD 58300100.0%
Helix BioPharma Corp. - CAD Infinity%
Microbix Biosystems Inc. 5.75 Million CAD 110.136%
Medicenna Therapeutics Corp. - CAD Infinity%
Oncolytics Biotech Inc. - CAD Infinity%
Sernova Corp. - CAD Infinity%